Okay, I need to figure out the correct drug for Zollinger-Ellison syndrome. Let me start by recalling what Zollinger-Ellison is. It's a condition where there's a gastrinoma, which is a tumor that secretes gastrin. High gastrin levels cause excessive stomach acid production, leading to peptic ulcers.

So, the main goal in treatment is to reduce acid secretion. The first-line drugs for acid suppression are proton pump inhibitors (PPIs), right? PPIs like omeprazole work by inhibiting the H+/K+ ATPase enzyme in the parietal cells, which is the final step in acid production. That makes sense because even though gastrin is driving acid production, blocking the pump would counteract that.

Wait, but what about other options? H2 blockers like ranitidine are used for ulcers too. But in Zollinger-Ellison, the acid production is so high that H2 blockers might not be sufficient. I remember reading that PPIs are more effective here. Also, since gastrin stimulates acid, the parietal cells are hyperactive, so a stronger inhibitor is needed.

Another thought: are there other drugs used in this condition? Maybe antrectomy or surgery, but that's more for the tumor. The medical management is definitely PPIs first. So the answer should be a PPI. Let me check the options again. The correct answer was supposed to be a PPI, like omeprazole. So the options must have included PPIs, H2 blockers, maybe others like antacids or surgery.

The wrong options would be H2 blockers, antacids, or maybe something else. For example, H2 blockers (like ranitidine) are less effective here. Antacids provide temporary relief but don't address the underlying acid production. Octreotide might be used to manage symptoms if PPIs aren't enough, but it's not the first choice. So the correct answer is the PPI.

**Core Concept** Zollinger-Ellison syndrome is characterized by a gastrin-secreting tumor (gastrinoma) causing excessive gastric acid production. The primary pharmacological goal is to inhibit acid secretion to manage ulcers and complications. Proton pump inhibitors (PPIs) are the cornerstone therapy due to their potent and sustained acid suppression.

**Why the Correct Answer is Right** Proton pump inhibitors (e.g., omeprazole, pantoprazole) irreversibly inhibit the H+/K+ ATPase enzyme (proton pump) in gastric parietal cells, blocking the final step of acid secretion. This is critical in Zollinger-Ellison syndrome, where hypergastrinemia drives excessive acid production that H2 receptor antagonists cannot fully counteract. PPIs are dosed in higher amounts (e.g., 40–80 mg/day) than in peptic ulcer disease to achieve adequate control.

**Why Each Wrong Option is Incorrect**
**Option A:** Histamine H2 receptor antagonists (e.g., ranitidine) reduce acid secretion but are less effective in Zollinger-Ellison due to the massive acid load from gastrin-driven stimulation.
**Option B:** Antacids neutralize gastric acid but do not inhibit secretion, making them inadequate for long-term management.

✓ Correct Answer: B. Omeprazole